EDN1 and diabetes mellitus: Crucially, when classifying patients with impaired kidney function according to their diabetes status and ET‐1 levels, individuals with diabetes and intermediate to high ET‐1 levels showed a markedly higher risk of MACE than the reference group, which consisted of those without diabetes and with low ET‐1 levels (Figure 3).